Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Scientific Reports|June 30, 2016
Site-specific covalent modifications of human insulin by catechol estrogens: Reactivity and induced structural and functional changesMing-Chun Ku, Chieh-Ming Fang, Juei-Tang Cheng, et al.
Transplant Immunology|September 12, 2003
Prolongation of heart allograft survival of rats treated by a Th2 inhibitorLi-wen Hsu, Shigeru Goto, Yu-chun Lin, et al.
Molecular Cancer Therapeutics|January 17, 2016
RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break-Inducing Anticancer DrugsHong-Yi Chang, Ting-Chia Chang, Wen-Ya Huang, et al.
International Journal of Molecular Sciences|September 3, 2016
A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in GliomaQiao-Li Lv, Lei Hu, Shu-Hui Chen, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SARJason Lamar, Jingdan Hu, Ana Belen Bueno, et al.
International Journal of Environmental Research and Public Health|October 21, 2016
Overexpression of RACK1 Promotes Metastasis by Enhancing Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Human GliomaQiao-Li Lv, Yuan-Tao Huang, Gui-Hua Wang, et al.
Frontiers in Pharmacology|December 28, 2020
Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating AutophagyQiao-Li Lv, Li-Chong Wang, Dang-Chi Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial-mesenchymal transition in vitro and predicts poor prognosis in gliomaQiao-Li Lv, Shu-Hui Chen, Xue Zhang, et al.
Transplant Immunology|February 20, 2007
Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressantsLi-Wen Hsu, Shigeru Goto, Toshiaki Nakano, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Bicyclic cyanothiazolidines as novel dipeptidyl peptidase 4 inhibitorsJuan M Betancort, David T Winn, Ruzhang Liu, et al.
Pageof 17